Data from the TCGA database demonstrated significant prolongation of survival in patients, whose AML cells expressed below average levels of FLNA (P = 0.0247, Fig. 5g), but this was not significant for CASR expression (Supplementary Fig. 18n). The gene discussed is FLNA; the disease is acute myeloid leukemia.